Back

Direct oral anticoagulants exhibit lower risks of mortality and bleeding compared to vitamin-k antagonists in atrial fibrillation patients on chronic hemodialysis: a meta-analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Antithrombotic and anticoagulant therapy in special populations Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hritvik Jain

All India Institute of Medical Sciences, Jodhpur (India)

8 More presentations in this session

Presentation thumbnail
Medication adherence and antithrombotic therapy outcomes: insights from a post-hoc analysis of the AFIRE trial
Doctor N. Chiba (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of differences in body mass index, body surface area and lean body mass on clinical outcomes in patients with atrial fibrillation receiving edoxaban: 4-year follow-up data from ETNA-AF-Europe
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Haemorrhagic risk in elderly patients with atrial fibrillation that develop low platelet count during direct oral anticoagulant treatment: insights from the ATHERO-AF study.
Doctor D. Menichelli (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Silent cerebral microvascular disease and longitudinal risk of cognitive decline in atrial fibrillation
Associate Professor Y. Kondo (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
The role of anticoagulation in atrial high-rate episodes: a meta-analysis
Doctor H. Ahmed (Omaha, US)
Abstract Slides Video

Access the full session

Session thumbnail
Antithrombotic and anticoagulant therapy in special populations

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Anticoagulation patterns in haemodialysis patients - how do we anticoagulate in the absence of indications?
thumbnail
Congress Presentation
Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Apixaban vs. warfarin for venous thromboembolism in renal impairment: a meta-analysis of efficacy and safety

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources